High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus

dc.contributor.authorSan Juan, Rafael
dc.contributor.authorViedma, Esther
dc.contributor.authorChaves, Fernando
dc.contributor.authorLalueza, Antonio
dc.contributor.authorFortún, Jesús
dc.contributor.authorLoza, Elena
dc.contributor.authorPujol Rojo, Miquel
dc.contributor.authorArdanuy Tisaire, María Carmen
dc.contributor.authorMorales, Isabel
dc.contributor.authorCueto, Marina de
dc.contributor.authorResino Foz, Elena
dc.contributor.authorMorales Cartagena, Alejandra
dc.contributor.authorRico, Alicia
dc.contributor.authorRomero, María P.
dc.contributor.authorOrellana, María Ángeles
dc.contributor.authorLópez Medrano, Francisco
dc.contributor.authorFernández Ruiz, Mario
dc.contributor.authorAguado, José María
dc.date.accessioned2018-12-11T13:21:26Z
dc.date.available2018-12-11T13:21:26Z
dc.date.issued2016-06
dc.date.updated2018-12-11T13:21:26Z
dc.description.abstractWe investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011 June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 mu g/mL and 0.5 mu g/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec662472
dc.identifier.issn1080-6040
dc.identifier.pmid27192097
dc.identifier.urihttps://hdl.handle.net/2445/126909
dc.language.isoeng
dc.publisherCenters for Disease Control and Prevention
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3201/eid2206.151709
dc.relation.ispartofEmerging Infectious Diseases, 2016, vol. 22, num. 6, p. 1057-1066
dc.relation.urihttps://doi.org/10.3201/eid2206.151709
dc.rights, 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationSang
dc.subject.classificationMalalties bacterianes
dc.subject.classificationFactors de risc en les malalties
dc.subject.classificationEfecte dels medicaments sobre els microorganismes
dc.subject.otherBlood
dc.subject.otherBacterial diseases
dc.subject.otherRisk factors in diseases
dc.subject.otherEffect of drugs on microorganisms
dc.titleHigh MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
662472.pdf
Mida:
1.52 MB
Format:
Adobe Portable Document Format